PITTSBURGH, Aug. 30, 2021 /PRNewswire/
-- Viatris Inc. (NASDAQ: VTRS) today announced the
company will take part in a virtual fireside chat at Citi's 16th
Annual BioPharma Conference on Friday,
September 10, 2021. Chief Executive Officer Michael Goettler and President Rajiv Malik will answer questions about the
company at 11:35 a.m. ET.
Interested parties can access a live webcast of the event at
investor.viatris.com. An archived version also will be available
following the live event and can be accessed at the same location
for a limited time.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company,
empowering people worldwide to live healthier at every stage of
life. We provide access to medicines, advance sustainable
operations, develop innovative solutions and leverage our
collective expertise to connect more people to more products and
services through our one-of-a-kind Global Healthcare
Gateway®. Formed in November
2020, Viatris brings together scientific, manufacturing and
distribution expertise with proven regulatory, medical and
commercial capabilities to deliver high-quality medicines to
patients in more than 165 countries and territories. Viatris'
portfolio comprises more than 1,400 approved molecules across a
wide range of therapeutic areas, spanning both non-communicable and
infectious diseases, including globally recognized brands, complex
generic and branded medicines, a growing portfolio of biosimilars
and a variety of over-the-counter consumer products. With a global
workforce of more than 40,000, Viatris is headquartered in the
U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at
viatris.com and investor.viatris.com, and connect with us on
Twitter
at @ViatrisInc, LinkedIn and YouTube.
![Viatris Logo (PRNewsfoto/Viatris Inc.) Viatris Logo (PRNewsfoto/Viatris Inc.)](https://mma.prnewswire.com/media/1499164/logo_Logo.jpg)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/viatris-inc-to-participate-in-citis-16th-annual-biopharma-conference-301364741.html
SOURCE Viatris Inc.